Barcelona Key Figure Fly to Amsterdam in New Efforts to Seize Ajax Prodigy De Jong From PSG


Key figures from the Barcelona board are believed to have flown to Amsterdam, with the aim of capturing Ajax starlet, Frenkie de Jong from the grip of his current applicants, Paris Saint-Germain.

The 21-year-old is one of the most coveted footballers in Europe, with his mature midfield appearance attracting the attention of a number of elite clubs. While people like Barcelona and Manchester City are believed to be the early pioneers to sign young players, Paris Saint-Germain has recently emerged as a favorite to close the deal.

UEFA League of Nations Group 1 & # 39; Germany v Netherlands & # 39;

However, with the January transfer window now in full swing, a crack team consisting of Barca board members had flown to the Dutch capital in an attempt to lure De Jong to the Nou Camp. According to Marca, Club president Josep Maria Bartomeu and football director Eric Abidal hope they will Attendance in Amsterdam will show how serious they are about the agreement.

General manager Pep Segura and assistant technical secretary Ramon Planes are also part of the negotiating team, and will be desperate to convince de Jong about the benefits of choosing La Liga rather than Ligue 1. The report also claims that the player will make a decision before the Champions League last 16 match his club against Real Madrid next month.

The PSG offer may be difficult for Ajax and de Jong to reject, with the Paris giants believed to be ready to pay in the region of € 80 million for central midfield services, and offer bumper contracts. Barça will not be able to match this offer, so it is necessary to hope that de Jong appreciates playing at a level higher than mere wealth.

Meanwhile, Barcelona is believed to give PSG midfielder Adrien Rabiot a one-week deadline to agree to a pre-contract with the club, as the Catalan club is increasingly impatient with the Frenchman. Rabiot's contract expires in the summer, but he has not agreed with the terms Blaugrana while continuing to assess the options.


Source link